Kite A Gilead Company

Sell-side

Financial Advisor, July 2021

Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD acquired by BioNTech

Kite, a Gilead Company, is a global biopharmaceutical company based in Santa Monica, California, with commercial manufacturing operations in North America and Europe. Kite’s singular focus is cell therapy to treat and potentially cure cancer. As the cell therapy leader, Kite has more approved CAR T indications to help more patients than any other company.

More Like This

May 2022

Sale of GeneDx, Inc., a Subsidiary of OPKO Health, Inc. (NASDAQ: OPK) to Sema4 Holdings Corp. (SMFR)

Financial Advisor

View Details
Apr 2022
Proven Behavior Solutions Logo

Strategic Investment From Health Enterprise Partners

Exclusive Financial Advisor

View Details
Feb 2022

Sale to Labcorp (NYSE: LH)

Exclusive Financial Advisor

View Details